Biologische Marker in der Epidemiologie: Begriffe, Anwendungen, Perspektiven (Teil II)

Translated title of the contribution: Biological Markers in Epidemiology: Concepts, applications, Perspectives (Part II)

W Hoffmann, U Latza, W Ahrens, K H Greiser, A Kroke, A Nieters, M B Schulze, M Steiner, C Terschuren, M Wjst

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The First part of this paper outlined terms and definitions in the context of the application of biological markers in epidemiological studies. Cardiovascular epidemiology served as an example for their historical development. The second part focusses on DNA-based biomarkers, practical and methodological dimensions of the use of biomarkers in analytic epidemiological studies as well as requirements in respect of validity and quality assurance. Most genetic polymorphisms have no impact on health. However, some can be used as biomarkers for individual sensitvity to exposures and susceptibility for specific diseases. The Human Genome Project has brought about a quantum leap in the development of genetic markers. The practical implications cannot presently be assessed with certainty. However, present and future research programmes of gene-environment interactions depend on,,traditional" epidemiological study designs, methods, and concepts. Ethical principles and data protection requirements apply equally to genetic and molecular epidemiology as do the,,Guidelines for Good Epidemiological Practice".

Original languageGerman
Pages (from-to)145-152
Number of pages8
JournalGesundheitswesen
Volume64
Issue number3
DOIs
Publication statusPublished - Mar 2002

Keywords

  • biomarker
  • individual susceptibility
  • individual sensitivity
  • molecular epidemiology
  • SNP
  • genetic polymorphism
  • validity
  • glutathione-S-transferase
  • lung-cancer
  • ataxia-telangiectasia
  • individual-responses
  • colorectal-cancer
  • depressed mood
  • X-irradiation
  • human genome
  • DNA-repair
  • risk

Cite this

Hoffmann, W., Latza, U., Ahrens, W., Greiser, K. H., Kroke, A., Nieters, A., ... Wjst, M. (2002). Biologische Marker in der Epidemiologie: Begriffe, Anwendungen, Perspektiven (Teil II). Gesundheitswesen, 64(3), 145-152. https://doi.org/10.1055/s-2002-22313

Biologische Marker in der Epidemiologie : Begriffe, Anwendungen, Perspektiven (Teil II). / Hoffmann, W ; Latza, U ; Ahrens, W ; Greiser, K H ; Kroke, A ; Nieters, A ; Schulze, M B ; Steiner, M ; Terschuren, C ; Wjst, M .

In: Gesundheitswesen, Vol. 64, No. 3, 03.2002, p. 145-152.

Research output: Contribution to journalArticle

Hoffmann, W, Latza, U, Ahrens, W, Greiser, KH, Kroke, A, Nieters, A, Schulze, MB, Steiner, M, Terschuren, C & Wjst, M 2002, 'Biologische Marker in der Epidemiologie: Begriffe, Anwendungen, Perspektiven (Teil II)', Gesundheitswesen, vol. 64, no. 3, pp. 145-152. https://doi.org/10.1055/s-2002-22313
Hoffmann W, Latza U, Ahrens W, Greiser KH, Kroke A, Nieters A et al. Biologische Marker in der Epidemiologie: Begriffe, Anwendungen, Perspektiven (Teil II). Gesundheitswesen. 2002 Mar;64(3):145-152. https://doi.org/10.1055/s-2002-22313
Hoffmann, W ; Latza, U ; Ahrens, W ; Greiser, K H ; Kroke, A ; Nieters, A ; Schulze, M B ; Steiner, M ; Terschuren, C ; Wjst, M . / Biologische Marker in der Epidemiologie : Begriffe, Anwendungen, Perspektiven (Teil II). In: Gesundheitswesen. 2002 ; Vol. 64, No. 3. pp. 145-152.
@article{538954f30e3f4e2996212c31798423d4,
title = "Biologische Marker in der Epidemiologie: Begriffe, Anwendungen, Perspektiven (Teil II)",
abstract = "The First part of this paper outlined terms and definitions in the context of the application of biological markers in epidemiological studies. Cardiovascular epidemiology served as an example for their historical development. The second part focusses on DNA-based biomarkers, practical and methodological dimensions of the use of biomarkers in analytic epidemiological studies as well as requirements in respect of validity and quality assurance. Most genetic polymorphisms have no impact on health. However, some can be used as biomarkers for individual sensitvity to exposures and susceptibility for specific diseases. The Human Genome Project has brought about a quantum leap in the development of genetic markers. The practical implications cannot presently be assessed with certainty. However, present and future research programmes of gene-environment interactions depend on,,traditional{"} epidemiological study designs, methods, and concepts. Ethical principles and data protection requirements apply equally to genetic and molecular epidemiology as do the,,Guidelines for Good Epidemiological Practice{"}.",
keywords = "biomarker, individual susceptibility, individual sensitivity, molecular epidemiology, SNP, genetic polymorphism, validity, glutathione-S-transferase, lung-cancer, ataxia-telangiectasia, individual-responses, colorectal-cancer, depressed mood, X-irradiation, human genome, DNA-repair, risk",
author = "W Hoffmann and U Latza and W Ahrens and Greiser, {K H} and A Kroke and A Nieters and Schulze, {M B} and M Steiner and C Terschuren and M Wjst",
year = "2002",
month = "3",
doi = "10.1055/s-2002-22313",
language = "German",
volume = "64",
pages = "145--152",
journal = "Gesundheitswesen",
issn = "0941-3790",
publisher = "Georg Thieme Verlag",
number = "3",

}

TY - JOUR

T1 - Biologische Marker in der Epidemiologie

T2 - Begriffe, Anwendungen, Perspektiven (Teil II)

AU - Hoffmann, W

AU - Latza, U

AU - Ahrens, W

AU - Greiser, K H

AU - Kroke, A

AU - Nieters, A

AU - Schulze, M B

AU - Steiner, M

AU - Terschuren, C

AU - Wjst, M

PY - 2002/3

Y1 - 2002/3

N2 - The First part of this paper outlined terms and definitions in the context of the application of biological markers in epidemiological studies. Cardiovascular epidemiology served as an example for their historical development. The second part focusses on DNA-based biomarkers, practical and methodological dimensions of the use of biomarkers in analytic epidemiological studies as well as requirements in respect of validity and quality assurance. Most genetic polymorphisms have no impact on health. However, some can be used as biomarkers for individual sensitvity to exposures and susceptibility for specific diseases. The Human Genome Project has brought about a quantum leap in the development of genetic markers. The practical implications cannot presently be assessed with certainty. However, present and future research programmes of gene-environment interactions depend on,,traditional" epidemiological study designs, methods, and concepts. Ethical principles and data protection requirements apply equally to genetic and molecular epidemiology as do the,,Guidelines for Good Epidemiological Practice".

AB - The First part of this paper outlined terms and definitions in the context of the application of biological markers in epidemiological studies. Cardiovascular epidemiology served as an example for their historical development. The second part focusses on DNA-based biomarkers, practical and methodological dimensions of the use of biomarkers in analytic epidemiological studies as well as requirements in respect of validity and quality assurance. Most genetic polymorphisms have no impact on health. However, some can be used as biomarkers for individual sensitvity to exposures and susceptibility for specific diseases. The Human Genome Project has brought about a quantum leap in the development of genetic markers. The practical implications cannot presently be assessed with certainty. However, present and future research programmes of gene-environment interactions depend on,,traditional" epidemiological study designs, methods, and concepts. Ethical principles and data protection requirements apply equally to genetic and molecular epidemiology as do the,,Guidelines for Good Epidemiological Practice".

KW - biomarker

KW - individual susceptibility

KW - individual sensitivity

KW - molecular epidemiology

KW - SNP

KW - genetic polymorphism

KW - validity

KW - glutathione-S-transferase

KW - lung-cancer

KW - ataxia-telangiectasia

KW - individual-responses

KW - colorectal-cancer

KW - depressed mood

KW - X-irradiation

KW - human genome

KW - DNA-repair

KW - risk

U2 - 10.1055/s-2002-22313

DO - 10.1055/s-2002-22313

M3 - Article

VL - 64

SP - 145

EP - 152

JO - Gesundheitswesen

JF - Gesundheitswesen

SN - 0941-3790

IS - 3

ER -